Health care resource utilisation in primary care prior to and after a diagnosis of Alzheimer's disease: a retrospective, matched case-control study in the United Kingdom

被引:38
|
作者
Chen, Lei [1 ]
Reed, Catherine [2 ]
Happich, Michael [1 ]
Nyhuis, Allen [1 ]
Lenox-Smith, Alan [3 ]
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA
[2] Lilly UK, Erl Wood Manor, Windlesham GU20 6PH, Surrey, England
[3] Lilly UK, Basingstoke RG24 9NL, Hants, England
来源
BMC GERIATRICS | 2014年 / 14卷
关键词
Alzheimer's disease; Dementia; United Kingdom; Primary care; GENERAL-PRACTICE; DEMENTIA; SYMPTOMS; RATES; OLDER; COST;
D O I
10.1186/1471-2318-14-76
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background: This study examined medical resource utilisation patterns in the United Kingdom (UK) prior to and following Alzheimer's disease (AD) diagnosis. Methods: A patient cohort aged 65 years and older with newly diagnosed AD between January 2008 and December 2010 was identified through the UK's Clinical Practice Research Datalink (CPRD). Patients with a continuous record in the CPRD (formerly the General Practice Research Database [GPRD]) for both the 3 years prior to, and the 1 year following, AD diagnosis were eligible for inclusion. A control cohort was identified by matching general older adult (GOA) patients to patients with AD based on year of birth, gender, region, and Charlson Comorbidity Index at a ratio of 2:1. Medical resource utilisation was calculated in 6-month intervals over the 4-year study period. Comparisons between AD and GOA control cohorts were conducted using conditional logistic regression for patient characteristics and a generalised linear model for resource utilisation. Results: Data for the AD cohort (N = 3,896) and matched GOA control cohort (N = 7,792) were extracted from the CPRD. The groups were 65% female and the AD cohort had a mean age of 79.9 years (standard deviation 6.5 years) at the date of diagnosis. Over the entire study period, the AD cohort had a significantly higher mean primary care consultation rate than the GOA cohort (p<.0001). While the GOA cohort primary care consultation rate gradually increased over the 4-year period (ranging from 5 to 7 consultations per 6-month period), increases were more pronounced in the AD cohort (ranging from 6 to 11 consultations per 6-month period, peaking during the 6-month periods immediately prior to and post diagnosis). The AD cohort also had a higher overall specialty referral rate than the GOA cohort over the 4-year period (37% vs. 25%, respectively; p<.0001); the largest difference was during the 6 months immediately prior to AD diagnosis (17% vs. 5%, respectively; p<.0001). Conclusions: In the UK, AD diagnosis is associated with significant increases in primary and secondary care resource utilisation, continuing beyond diagnosis. This evidence may be important to health care commissioners to facilitate effective mobilisation of appropriate AD-related health care resources.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Associations between proton pump inhibitors and Alzheimer's disease: a nested case-control study using a Korean nationwide health screening cohort
    Choi, Hyo Geun
    Kim, Joo-Hee
    Kim, Ji Hee
    Kim, Eun Soo
    Park, Ha Young
    Min, Kyueng-Whan
    Kwon, Mi Jung
    ALZHEIMERS RESEARCH & THERAPY, 2022, 14 (01)
  • [42] Health care costs before and after diagnosis of depression in patients with unexplained pain: a retrospective cohort study using the United Kingdom General Practice Research Database
    Reed, Catherine
    Hong, Jihyung
    Novick, Diego
    Lenox-Smith, Alan
    Happich, Michael
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 37 - 47
  • [43] Association of Folate Metabolites and Mitochondrial Function in Peripheral Blood Cells in Alzheimer's Disease: A Matched Case-Control Study
    Lv, Xin
    Zhou, Dongtao
    Ge, Baojin
    Chen, Hui
    Du, Yue
    Liu, Shuai
    Ji, Yong
    Sun, Changqing
    Wang, Guangshun
    Gao, Yuxia
    Lia, Wen
    Huang, Guowei
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 70 (04) : 1133 - 1142
  • [44] Impact of Prior Antibiotic Use in Primary Care on Escherichia coli Resistance to Third Generation Cephalosporins: A Case-Control Study
    Fulgenzio, Chiara
    Massari, Marco
    Traversa, Giuseppe
    Da Cas, Roberto
    Ferrante, Gianluigi
    Aschbacher, Richard
    Moser, Verena
    Pagani, Elisabetta
    Vestri, Anna Rita
    Massidda, Orietta
    Kurotschka, Peter Konstantin
    ANTIBIOTICS-BASEL, 2021, 10 (04):
  • [45] Clinical features in primary care electronic records before diagnosis of ankylosing spondylitis: a nested case-control study
    Mohammed T. Bashir
    Lisa Iversen
    Christopher Burton
    BMC Family Practice, 21
  • [46] Home-Based Primary Care for Older Adults: Matched Case-Control Evaluation of Program's Impact on Healthcare Utilization
    Kling, Samantha M. R.
    Garvert, Donn W. W.
    Lessios, Anna Sophia
    Yefimova, Maria
    Martin, Marina
    Sheffrin, Meera
    Winget, Marcy
    HOME HEALTH CARE MANAGEMENT AND PRACTICE, 2023, 35 (03) : 213 - 221
  • [47] Clinical features in primary care electronic records before diagnosis of ankylosing spondylitis: a nested case-control study
    Bashir, Mohammed Talha
    Iversen, Lisa
    Burton, Christopher
    BMC FAMILY PRACTICE, 2020, 21 (01)
  • [48] Return-to-Work after depression - evaluation of a retrospective case-control study of an operational integrated care model
    Reifferscheid, Alina
    Wege, Natalia
    Riesbeck, Mathias
    Janssen, Birgit
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2019, 87 (02) : 121 - 127
  • [49] Effect of polycyclic aromatic hydrocarbon exposure on amnestic mild cognitive impairment and Alzheimer's disease: A matched case-control study
    Jang, Heeseon
    Sohn, Jungwoo
    Kim, Hee Jin
    Seo, Sang Won
    Noh, Young
    Koh, Sang-Baek
    Cho, Jaelim
    Kim, Changsoo
    HELIYON, 2024, 10 (15)
  • [50] Effect of Fluoroquinolone Use in Primary Care on the Development and Gradual Decay of Escherichia coli Resistance to Fluoroquinolones: A Matched Case-Control Study
    Kurotschka, Peter Konstantin
    Fulgenzio, Chiara
    Da Cas, Roberto
    Traversa, Giuseppe
    Ferrante, Gianluigi
    Massidda, Orietta
    Gagyor, Ildiko
    Aschbacher, Richard
    Moser, Verena
    Pagani, Elisabetta
    Alegiani, Stefania Spila
    Massari, Marco
    ANTIBIOTICS-BASEL, 2022, 11 (06):